Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6124208rdf:typepubmed:Citationlld:pubmed
pubmed-article:6124208lifeskim:mentionsumls-concept:C0038587lld:lifeskim
pubmed-article:6124208lifeskim:mentionsumls-concept:C0001645lld:lifeskim
pubmed-article:6124208lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:6124208lifeskim:mentionsumls-concept:C2003855lld:lifeskim
pubmed-article:6124208pubmed:issue4 Suppllld:pubmed
pubmed-article:6124208pubmed:dateCreated1982-8-7lld:pubmed
pubmed-article:6124208pubmed:abstractTextClinical studies were performed with groups of patients with ischaemic heart disease, patients with hyperthyroidism, and normal subjects, to investigate the possibility of a beta blocker withdrawal syndrome, by measurments of heart rate under conditions of increased sympathetic drive provided by standing with vasodilatation or by Valsalva's manoeuvre. A rebound increase in heart rate to levels significantly higher than the control heart rate off treatment was observed 2-5 days after stopping one or more weeks' treatment with dl-propranolol (160 mg/day), atenolol (200 mg/day), acebutolol (400 mg/day) or oxprenolol (160 mg/day).lld:pubmed
pubmed-article:6124208pubmed:languageenglld:pubmed
pubmed-article:6124208pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:citationSubsetIMlld:pubmed
pubmed-article:6124208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6124208pubmed:statusMEDLINElld:pubmed
pubmed-article:6124208pubmed:monthOctlld:pubmed
pubmed-article:6124208pubmed:issn0304-4602lld:pubmed
pubmed-article:6124208pubmed:authorpubmed-author:RossJJlld:pubmed
pubmed-article:6124208pubmed:authorpubmed-author:LewisMMlld:pubmed
pubmed-article:6124208pubmed:authorpubmed-author:HendersonAAlld:pubmed
pubmed-article:6124208pubmed:authorpubmed-author:SheridanDDlld:pubmed
pubmed-article:6124208pubmed:issnTypePrintlld:pubmed
pubmed-article:6124208pubmed:volume10lld:pubmed
pubmed-article:6124208pubmed:ownerNLMlld:pubmed
pubmed-article:6124208pubmed:authorsCompleteYlld:pubmed
pubmed-article:6124208pubmed:pagination25-8lld:pubmed
pubmed-article:6124208pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:meshHeadingpubmed-meshheading:6124208-...lld:pubmed
pubmed-article:6124208pubmed:year1981lld:pubmed
pubmed-article:6124208pubmed:articleTitleFactors relating to the beta blocker withdrawal syndrome.lld:pubmed
pubmed-article:6124208pubmed:publicationTypeJournal Articlelld:pubmed